Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade

By Haneda M.   Sugimoto T.   Kikkawa R.  

European Journal of Pharmacology, Vol. 365, Iss. 1, 1999-01 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Immunosuppressant rapamycin inhibits protein kinase C and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis

By Oh C.-D.   Kim S.-J.   Ju J.-W.   Song W.K.   Kim J.-H.   Yoo Y.J.   Chun J.-S.  

European Journal of Pharmacology, Vol. 427, Iss. 3, 2001-09 ,pp. : 175-185

Elsevier

Access to resources Recommend Favorite

Mitogen-activated protein kinase phosphatase-1 – a potential therapeutic target in metabolic disease

By Roth Flach Rachel J   Bennett Anton M  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1323-1332

Informa Healthcare

Access to resources Recommend Favorite

Targeting Mitogen-Activated Protein Kinase Phosphatase-1 (MKP-1): Structure-Based Design of MKP-1 Inhibitors and Upregulators

By  

Current Medicinal Chemistry, Vol. 19, Iss. 2, 2012-01 ,pp. : 163-173

Bentham Science Publishers

Access to resources Recommend Favorite

T-588 inhibits astrocyte apoptosis via mitogen-activated protein kinase signal pathway

By Takuma K.   Fujita T.   Kimura Y.   Tanabe M.   Yamamuro A.   Lee E.   Mori K.   Koyama Y.   Baba A.   Matsuda T.  

European Journal of Pharmacology, Vol. 399, Iss. 1, 2000-06 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite